Antibiotics brought by NTN SwissBiotech

​Antimicrobial resistance (AMR) of pathogenic bacteria is an emerging global health problem, which threatens the achievements of modern medicine. For several decades, lack of economic incentives prevented companies to develop novel antimicrobial drugs. Today, an increasing number of bacterial infections cannot be cured with the existing arsenal of antibiotics due to the spread of multidrug resistant strains. The forum “Antibiotics”, organized by NTN SwissBiotech, brings together leaders in the field of antibiotic development from academia and industry to discuss technical innovations in order to overcome the AMR crisis. The invited speakers focus on novel concepts and targets to treat multidrug resistant pathogens.






Basel Life 2018, Congress Center Basel

 ‭(Hidden)‬ Anmeldeformular ‭[2]‬

 ‭(Hidden)‬ Anmeldeformular ‭[1]‬

Further information on this content